posted on 2019-09-24, 13:36authored byCecilia Yamil Chain, Dênio Emanuel Pires Souto, María Laura Sbaraglini, Carlos A. Labriola, María Antonieta Daza Millone, Eduardo Alejandro Ramirez, José Sebastián Cisneros, Constanza Lopez-Albizu, Karenina Scollo, Lauro T. Kubota, Andrés
Mariano Ruiz, María Elena Vela
trans-Sialidase and cruzipain are important virulence factors from Trypanosoma cruzi, the etiological agent of Chagas disease,
that have highly antigenic domains in their structure and were reported
as potential tools for diagnosis of the illness. The aim of the present
study is to assess the possibility of using cruzipain and the catalytic
domain of trans-sialidase in a Surface Plasmon Resonance-based
immunosensor for the diagnosis of chronic Chagas disease. Immunoassays
carried out with canine sera verified that cruzipain allows the detection
of anti-Trypanosoma cruzi antibodies whereas recombinant trans-sialidase did not yield specific detections, due to
the high dilutions of serum used in the immunoassays that hinder the
possibility to sense the specific low titer antibodies. The developed
cruzipain-based biosensor, whose price per assay is comparable to
a commercial enzyme-linked immunosorbent assay (ELISA), was successfully
applied for the rapid quantification of specific antibodies against Trypanosoma cruzi in fresh human sera showing an excellent
agreement with ELISA.